文献速递呼吸衰竭与机械通气心脑血管急症

社区急诊科使用年龄校正D-二聚体评估肺栓塞的效果

Effect of Using an Age-adjusted D-dimer to Assess for Pulmonary Embolism in Community Emergency Departments.
PubMed 文献 · Acad Emerg Med · 2020-12-24
一句话结论将实验室D-二聚体参考区间改为年龄校正区间未减少先进胸部影像检查,也未增加30天不良事件,但依从性差可能削弱了干预效果。

该回顾性中断时间序列分析纳入2014年4月至2016年4月期间在社区急诊科因疑似肺栓塞就诊的50岁以上患者共10,534例次(实施前5,153例次,实施后5,381例次)。主要结局为先进诊断影像使用率,次要结局为30天死亡率或肺栓塞诊断。实施年龄校正D-二聚体参考区间后,先进胸部影像使用率从35.9%降至33%,月趋势变化无统计学意义(OR=0.98,95%CI 0.96-1.00);30天不良事件率无变化。然而,实施后D-二聚体低于年龄校正参考区间但高于历史500 ng/mL FEU参考区间的患者中,仍有30%接受了影像检查,提示对年龄校正区间的依从性不佳。

要点

  • 在50岁以上疑似肺栓塞的社区急诊患者中,实施年龄校正D-二聚体参考区间后,先进胸部影像使用率从35.9%降至33%,月趋势OR=0.98(95%CI 0.96-1.00),无统计学意义。
  • 实施年龄校正D-二聚体阈值后,30天不良事件(漏诊肺栓塞或死亡)率无变化。
  • 实施后,D-二聚体低于年龄校正参考区间但高于500 ng/mL FEU的患者中,仍有30%接受了先进影像检查,表明临床对年龄校正区间的依从性差。
  • D-二聚体低于500 ng/mL FEU的患者中,实施前后先进影像使用率相似(实施前5.8% vs 实施后6.8%)。

适用人群与场景

  • 年龄>50岁、在社区急诊科因疑似肺栓塞接受评估的患者(2014年4月至2016年4月)。

诊断标准与关键阈值

  • 年龄校正D-二聚体参考区间:原文未给出具体计算公式或界值,仅提及将实验室报告的D-二聚体参考区间改为年龄校正区间。
  • 历史参考区间为500 ng/mL纤维蛋白原等效单位(FEU)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性中断时间序列分析;样本量:10,534例次急诊就诊(实施前5,153例次,实施后5,381例次);人群:>50岁疑似肺栓塞患者;干预:将实验室D-二聚体参考区间改为年龄校正区间;对照:历史500 ng/mL FEU参考区间。
  • 主要终点:先进诊断影像使用率实施前35.9% vs 实施后33%;年龄校正D-二聚体实施后月度影像使用趋势变化OR=0.98(95%CI 0.96-1.00),无统计学意义。
  • 关键次要终点:30天不良事件(漏诊肺栓塞或死亡)率无变化。
  • 其他结果:D-二聚体<500 ng/mL FEU的患者中,影像使用率实施前5.8% vs 实施后6.8%;实施后D-二聚体低于年龄校正参考区间但高于500 ng/mL FEU的患者中,30%接受了影像检查。

证据类型、等级与局限

  • 证据类型:回顾性观察性研究(中断时间序列分析),单中心(社区急诊科)。
  • 局限:回顾性设计;依从性差可能削弱干预效果;原文未提及证据等级或推荐强度。

对床旁实践的改变

  • 将实验室D-二聚体参考区间改为年龄校正区间,在本研究中未显著减少先进胸部影像检查,也未增加30天不良事件。
  • 临床对年龄校正区间的依从性差(30%符合年龄校正排除标准但高于500 ng/mL FEU的患者仍接受影像),提示仅改变实验室参考区间可能不足以改变临床行为。
  • 适用人群:>50岁疑似肺栓塞的急诊患者;不适用人群:原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The objective of this study was to evaluate the effect of changing the laboratory-reported D-dimer reference intervals to age-adjusted reference intervals on the use of advanced chest imaging and 30-day adverse events among emergency department (ED) encounters.

METHODS: A retrospective interrupted time-series analysis of ED encounters for patients > 50 years evaluated for suspected pulmonary embolism (PE) from April 2014 to April 2016. The primary outcome was use of advanced diagnostic imaging, and the secondary outcome was 30-day mortality or PE diagnosis. Secondary analyses also quantified delayed PE diagnoses pre- and postintervention. A generalized estimating equation segmented logistic regression model, adjusting for patient and facility characteristics, was used to determine changes in odds of diagnostic imaging and 30-day mortality or PE diagnoses.

RESULTS: A total of 10,534 (5,153 pre- and 5,381 postimplementation) ED encounters were included. Advanced imaging was obtained in 35.9% of pre- versus 33% of postimplementation encounters. Age-adjusted D-dimer (AADD) showed a small and nonsignificant decrease in month-to-month trends of advanced chest imaging postimplementation (odds ratio [OR] = 0.98, 95% confidence interval [CI] = 0.96 to 1.00). Use of advanced imaging in patients with D-dimer values lower than 500 ng/mL fibrinogen-equivalent units (FEU) was similar in the preintervention (5.8%) and postintervention (6.8%) periods. However, imaging was obtained in 30% of patients postintervention with a D-dimer result less than AADD reference interval , but more than the historical 500 ng/mL FEU reference interval. Implementing an AADD threshold demonstrated no change in the rate of 30-day adverse events (missed PE or mortality).

CONCLUSION: Changing the laboratory-reported D-dimer reference intervals for evaluation of PE was not associated with reduction in advanced chest imaging and did not increase 30-day adverse events. However, there was substantial noncompliance with the age-adjusted reference intervals in the postintervention period likely blunting the impact of this intervention.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Ghobadi A, Lin B, Musigdilok VV, et al. Effect of Using an Age-adjusted D-dimer to Assess for Pulmonary Embolism in Community Emergency Departments. Acad Emerg Med. 2020. PMID: 33206443. doi:10.1111/acem.14175

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。